Mechanisms of Preconditioning Exercise-Induced Neurovascular Protection in Stroke

Ischemic stroke is a leading cause of death and disability. Tissue plasminogen activator is the only U.S. Food and Drug Administration approved thrombolytic therapy for ischemic stroke patients till date. However, its use is limited due to increased risk of bleeding and narrow therapeutic window. Mo...

Full description

Bibliographic Details
Main Authors: Sherif Hafez, Zeina Eid, Sara Alabasi, Yasenya Darwiche, Sara Channaoui, David C. Hess
Format: Article
Language:English
Published: Korean Stroke Society 2021-09-01
Series:Journal of Stroke
Subjects:
Online Access:http://www.j-stroke.org/upload/pdf/jos-2020-03006.pdf

Similar Items